Rankings
▼
Calendar
ARVN Q1 2021 Earnings — Arvinas, Inc. Revenue & Financial Results | Market Cap Arena
ARVN
Arvinas, Inc.
$907M
Q1 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$6M
-11.9% YoY
Gross Profit
$6M
100.0% margin
Operating Income
-$42M
-758.2% margin
Net Income
-$41M
-745.5% margin
EPS (Diluted)
$-0.84
QoQ Revenue Growth
+148.0%
Cash Flow
Operating Cash Flow
-$39M
Free Cash Flow
-$40M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$682M
Total Liabilities
$66M
Stockholders' Equity
$615M
Cash & Equivalents
$346M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$6M
$6M
-11.9%
Gross Profit
$6M
$6M
-11.9%
Operating Income
-$42M
-$23M
-78.1%
Net Income
-$41M
-$22M
-88.6%
← FY 2021
All Quarters
Q2 2021 →